Factor Nutrition presents study on supplement supporting memory
BOSTON — Factor Nutrition Labs on Monday presented a study supporting supplementation with its FocusFactor product to improve brain function before the Gerontological Society of America.
The clinical study of 89 adults used the Rey Auditory Verbal Learning Test, a standardized neuropsychological test and one of the most commonly used tests of memory in psychopharmacology research, the company stated. The study also used CogScreen, a computer-administered neuropsychological test battery developed for the Federal Aviation Administration for evaluating the cognitive functioning of pilots.
The mean age of subjects who participated was 49.1 years. The study was conducted over a six-week period. The clinical study of FocusFactor was sponsored by Factor Nutrition and was conducted by Cognitive Research, a full-service contract research organization.
“The clinical study demonstrated that, compared to placebo, FcousFactor improved abilities referred to as memory, concentration and focus in healthy adults,” Cognitive Research president Gary Kay said. “Following six weeks of treatment, subjects who received FocusFactor had a mean increase in recall of 6.5 words compared to 4.5 words for those who received placebo.”
Citi: Flu season to peak later in 2012 than it did last year
NEW YORK — Citi Investment Research & Analysis is projecting that the peak of flu season may occur beyond last season’s peak of January/February, a factor that may place a negative drag on retail same-store sales results over first quarter 2012.
"Flu activity in week 44 (the week ended Nov. 5) decreased significantly year over year and also declined versus last week," wrote Citi analyst Deborah Weinswig in a research note earlier this week. "Due to the weak early season result, we believe the 2011-2012 flu season could peak later than 2010-2011’s January/February peak, which will likely have a negative impact on Rx same-store sales during the end of 2011 and the beginning of 2012," she noted. "In addition, we believe that increased competition among the drug stores, supermarkets and discounters has resulted in lower flu vaccination numbers at each retailer versus last year. We will continue to monitor this season’s flu numbers and gauge its impact on the drug stores’ same-store sales results."
Season-to-date through week 44, the number of positive reports of influenza as a percentage of total cases tested was 0.8%, versus 3.9% during the same week-ending date last year (62 cases-to-date TY vs. 395 LY). And the U.S. Outpatient Influenza-like Illness Surveillance Network reported that 1.3% of patient visits in week 44 were due to ILI, which is below the national baseline of 2.4%, above the 1.2% reported last week, and in line with the 1.3% reported during the same week-ending date last year.
Cold-Eeze wins Parent Tested, Parent Approved seal
DOYLESTOWN, Pa. — ProPhase Labs on Thursday announced that its Cold-Eeze product has been awarded the Parent Tested, Parent Approved Winner’s Seal of Approval.
PTPA Media has North America’s largest volunteer parent testing community, with more than 40,000 parents. The seal of approval is awarded based on quality, effectiveness and value.
"This Seal of Approval reflects the high standards that we set for Cold-Eeze, and we are honored to receive this award," stated Ted Karkus, chairman and CEO ProPhase Labs. "This recognition highlights the benefits and value that Cold-Eeze offers to families during the cough and cold season."
"At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," stated PTPA CEO Sharon Vinderine. "When consumers search for our Seal of Approval on product packaging and websites, they are essentially searching for validation from their peers."
Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter here.